Improved Quality of Life at Lower Cost of Care

Participants in the health care system possess different motivations but share a common goal - a healthy individual enjoying a high quality of life.

The Cardiolert System addresses concerns of all parties, caregivers, payers, and patients.

Heart failure is a disease of the circulatory system. As the heart weakens blood circulation diminishes. The body is starved for oxygen. Fluids accumulate in the lungs. Victims suffer from exhaustion and shortness of breath. In its later stages the patient is completely incapacitated.

The goal of treatment is the utilize medication to treat the causes of diminished capacity. With proper medication therapy most patients can live normal lives. The difficulty in determining medication therapy is well documented. It is this difficulty that results in a lower quality of life and increased costs of care.

Heart failure afflicts five million Americans. It is the single costliest disease consuming over five million hospital days at a cost of $26 billion for hospitalization alone. If cost measures suffering, it is a painful disease.

Physicians struggle with medication strategies to produce optimal cardiovascular function. A critical problem is the lack of information; information provided by the Cardiolert System. The comprehensive hemodynamic analysis delivers the information necessary to understand the effect of and accurately adjust therapy.

Physicians skilled in the use of hemodynamic profiles produce outstanding therapy results. One physician, in a decade of treating heart failure, hospitalized only one patient. A significant improvement over the national average.

This is the Cardiolert Systems goal: make hemodynamic testing and therapy available to every victim of heart failure raising the quality life throughout the population.